344 related articles for article (PubMed ID: 35054783)
1. Connexin 43: A Target for the Treatment of Inflammation in Secondary Complications of the Kidney and Eye in Diabetes.
Cliff CL; Williams BM; Chadjichristos CE; Mouritzen U; Squires PE; Hills CE
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054783
[TBL] [Abstract][Full Text] [Related]
2. Connexin-43 hemichannels orchestrate NOD-like receptor protein-3 (NLRP3) inflammasome activation and sterile inflammation in tubular injury.
Roger E; Chadjichristos CE; Kavvadas P; Price GW; Cliff CL; Hadjadj S; Renciot J; Squires PE; Hills CE
Cell Commun Signal; 2023 Sep; 21(1):263. PubMed ID: 37770948
[TBL] [Abstract][Full Text] [Related]
3. Targeting connexin hemichannels to control the inflammasome: the correlation between connexin43 and NLRP3 expression in chronic eye disease.
Mugisho OO; Rupenthal ID; Paquet-Durand F; Acosta ML; Green CR
Expert Opin Ther Targets; 2019 Oct; 23(10):855-863. PubMed ID: 31554417
[No Abstract] [Full Text] [Related]
4. Mechanisms Underlying Connexin Hemichannel Activation in Disease.
Van Campenhout R; Gomes AR; De Groof TWM; Muyldermans S; Devoogdt N; Vinken M
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33800706
[TBL] [Abstract][Full Text] [Related]
5. Collagen I Modifies Connexin-43 Hemichannel Activity via Integrin α2β1 Binding in TGFβ1-Evoked Renal Tubular Epithelial Cells.
Potter JA; Price GW; Cliff CL; Green CR; Squires PE; Hills CE
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807408
[TBL] [Abstract][Full Text] [Related]
6. Transforming Growth Factor Beta 1 Drives a Switch in Connexin Mediated Cell-to-Cell Communication in Tubular Cells of the Diabetic Kidney.
Hills C; Price GW; Wall MJ; Kaufmann TJ; Chi-Wai Tang S; Yiu WH; Squires PE
Cell Physiol Biochem; 2018; 45(6):2369-2388. PubMed ID: 29587265
[TBL] [Abstract][Full Text] [Related]
7. Blocking connexin 43 hemichannel-mediated ATP release reduces communication within and between tubular epithelial cells and medullary fibroblasts in a model of diabetic nephropathy.
Williams BM; Cliff CL; Demirel I; Squires PE; Hills CE
Diabet Med; 2022 Dec; 39(12):e14963. PubMed ID: 36256487
[TBL] [Abstract][Full Text] [Related]
8. Connexin43 hemichannel block inhibits NLRP3 inflammasome activation in a human retinal explant model of diabetic retinopathy.
Louie HH; Shome A; Kuo CY; Rupenthal ID; Green CR; Mugisho OO
Exp Eye Res; 2021 Jan; 202():108384. PubMed ID: 33285185
[TBL] [Abstract][Full Text] [Related]
9. Connexin43 hemichannels: A potential drug target for the treatment of diabetic retinopathy.
Mugisho OO; Green CR; Zhang J; Acosta ML; Rupenthal ID
Drug Discov Today; 2019 Aug; 24(8):1627-1636. PubMed ID: 30690195
[TBL] [Abstract][Full Text] [Related]
10. Harnessing the therapeutic potential of antibodies targeting connexin hemichannels.
Buratto D; Donati V; Zonta F; Mammano F
Biochim Biophys Acta Mol Basis Dis; 2021 Apr; 1867(4):166047. PubMed ID: 33418036
[TBL] [Abstract][Full Text] [Related]
11. At the cross-point of connexins, calcium, and ATP: blocking hemichannels inhibits vasoconstriction of rat small mesenteric arteries.
Bol M; Wang N; De Bock M; Wacquier B; Decrock E; Gadicherla A; Decaluwé K; Vanheel B; van Rijen HV; Krysko DV; Bultynck G; Dupont G; Van de Voorde J; Leybaert L
Cardiovasc Res; 2017 Feb; 113(2):195-206. PubMed ID: 27677282
[TBL] [Abstract][Full Text] [Related]
12. Isoform-specific phosphorylation-dependent regulation of connexin hemichannels.
Alstrøm JS; Hansen DB; Nielsen MS; MacAulay N
J Neurophysiol; 2015 Nov; 114(5):3014-22. PubMed ID: 26400258
[TBL] [Abstract][Full Text] [Related]
13. Connexin targeting peptides as inhibitors of voltage- and intracellular Ca2+-triggered Cx43 hemichannel opening.
Wang N; De Bock M; Decrock E; Bol M; Gadicherla A; Bultynck G; Leybaert L
Neuropharmacology; 2013 Dec; 75():506-16. PubMed ID: 24007825
[TBL] [Abstract][Full Text] [Related]
14. Connexin 43 Hemichannel Activity Promoted by Pro-Inflammatory Cytokines and High Glucose Alters Endothelial Cell Function.
Sáez JC; Contreras-Duarte S; Gómez GI; Labra VC; Santibañez CA; Gajardo-Gómez R; Avendaño BC; Díaz EF; Montero TD; Velarde V; Orellana JA
Front Immunol; 2018; 9():1899. PubMed ID: 30158937
[TBL] [Abstract][Full Text] [Related]
15. Connexin and pannexin hemichannels in inflammatory responses of glia and neurons.
Bennett MV; Garré JM; Orellana JA; Bukauskas FF; Nedergaard M; Sáez JC
Brain Res; 2012 Dec; 1487():3-15. PubMed ID: 22975435
[TBL] [Abstract][Full Text] [Related]
16. The inflammasome pathway is amplified and perpetuated in an autocrine manner through connexin43 hemichannel mediated ATP release.
Mugisho OO; Green CR; Kho DT; Zhang J; Graham ES; Acosta ML; Rupenthal ID
Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):385-393. PubMed ID: 29158134
[TBL] [Abstract][Full Text] [Related]
17. Emerging issues of connexin channels: biophysics fills the gap.
Harris AL
Q Rev Biophys; 2001 Aug; 34(3):325-472. PubMed ID: 11838236
[TBL] [Abstract][Full Text] [Related]
18. Connexin hemichannels and gap junction channels are differentially influenced by lipopolysaccharide and basic fibroblast growth factor.
De Vuyst E; Decrock E; De Bock M; Yamasaki H; Naus CC; Evans WH; Leybaert L
Mol Biol Cell; 2007 Jan; 18(1):34-46. PubMed ID: 17079735
[TBL] [Abstract][Full Text] [Related]
19. Connexin-mediated cell communication in the kidney: A potential therapeutic target for future intervention of diabetic kidney disease?: Joan Mott Prize Lecture.
Price GW; Potter JA; Williams BM; Cliff CL; Squires PE; Hills CE
Exp Physiol; 2020 Feb; 105(2):219-229. PubMed ID: 31785013
[TBL] [Abstract][Full Text] [Related]
20. Connexin 43 Hemichannel as a Novel Mediator of Sterile and Infectious Inflammatory Diseases.
Li W; Bao G; Chen W; Qiang X; Zhu S; Wang S; He M; Ma G; Ochani M; Al-Abed Y; Yang H; Tracey KJ; Wang P; D'Angelo J; Wang H
Sci Rep; 2018 Jan; 8(1):166. PubMed ID: 29317708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
